|
|
Vaccine Detail
|
Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted by GSK |
| Vaccine Information |
- Vaccine Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted by GSK
- Target Pathogen: Influenza virus
- Target Disease: Influenza (flu)
- Product Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Manufacturer: GlaxoSmithKline
- Type: Inactivated or "killed" vaccine
- Status: Licensed
- Location Licensed: USA
- Host Species for Licensed Use: Human
- Preservative: Thimerosal
- Allergen: Eggs
- Immunization Route: Intramuscular injection (i.m.)
- Approved Age for Licensed Use: 6 months of age and older
- Description: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is a vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons (6 months and older) at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine. (FDA: H5N1 GSK)
|
| Host Response |
|
|
| References |
FDA: H5N1 GSK: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted [https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/UCM376464.pdf]
|
|
